Home/Filings/4/0001415889-24-019028
4//SEC Filing

Prince Joshua S. 4

Accession 0001415889-24-019028

CIK 0001411685other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 6:10 PM ET

Size

5.0 KB

Accession

0001415889-24-019028

Insider Transaction Report

Form 4
Period: 2024-06-28
Prince Joshua S.
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2024-06-28$2.96/sh+2,671$7,9012,671 total
Footnotes (1)
  • [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended.

Issuer

Vistagen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1
  • filerCIK 0001998663

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:10 PM ET
Size
5.0 KB